In Brief: Matritech
This article was originally published in The Gray Sheet
Executive Summary
Matritech: Submits 510(k) for its NuMA test kit to aid in the management of colon cancer patients, the Newton, Massachusetts-based firm says Oct. 16. The blood-based test "correlates levels of [Nuclear Matrix Protein] in body fluids to the presence of cancer," the firm adds. NuMA is an NMP found to be present in elevated levels in colon cancer cells...